Basic Information
SanBio is a regenerative medicine company with its cell-based products in various stages of research, development, and clinical trials. Its proprietary cell-based product, SB623, is currently undergoing a Phase 2b clinical trial.
SanBio, Co., Ltd.
Tokyo,Japan
15~50 people
February 01, 2001
info@sanbio.jp
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios